Way Biosolutions, Inc.
StreetZero Signal 72
About Way Biosolutions, Inc.
Way Biosolutions, Inc., operating as WayBio, is a biotechnology company that provides DNA assembly, modification, and validation services. It positions itself as a DNA foundry built for teams that need to move fast on complex constructs including repeats and high GC content. The company is headquartered at 20 Acorn Park Drive, 5th Floor, Cambridge, MA 02140, United States.
LATEST FUNDINGPrivate Placement
$2.0M
Announced 2026-09-25
TOTAL RAISED$2,000,000
IN THE NEWS
- 🔗 Affigenix Biosolutions - 2026 Company Profile, Team, Funding, Competitors & Financials - Tracxn
- 🔗 Waybio
- 🔗 Emergent BioSolutions - 2026 Company Profile, Team, Funding, Competitors & Financials - Tracxn
- 🔗 Novonesis | The time for biosolutions is now
- 🔗 Synthetic Biology Investment Reached a New Record of Nearly $8 Billion in 2020 — What Does This Mean For 2021?
EMPLOYEES—
FOUNDED—
HQCambridge, MA, United States
Industry
Biotechnology
Tags
BiotechnologyDNA FoundrySynthetic BiologyB2B
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Raised $2M in private placement with undisclosed investors.
- Operates a DNA foundry service in Cambridge, MA.
- Specializes in complex plasmid constructs including repeats and high GC content.
- Receives positive feedback from biotech partners on quality and technical support.
Ask StreetZero about Way Biosolutions, Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account